Bal Pharma
₹102.65
-0.15 (-0.15%)
18 May, 2024 16:02 BSE: 524824
NSE: BALPHARMAISIN: INE083D01012
Start SIP in Bal Pharma
Start SIPBal Pharma Performance
Day Range
- Low 102
- High 105
52 Week Range
- Low 81
- High 132
- Open Price105
- Previous Close103
- Volume4492
Bal Pharma Financials
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 81 | 92 | 70 | 82 |
| Operating Expenses Qtr Cr | 74 | 85 | 63 | 74 |
| Operating Profit Qtr Cr | 8 | 8 | 7 | 8 |
| Depreciation Qtr Cr | 3 | 2 | 2 | 2 |
| Interest Qtr Cr | 4 | 4 | 4 | 4 |
| Tax Qtr Cr | 0 | 1 | 0 | 1 |
| Net Profit Qtr Cr | 1 | 2 | 1 | 2 |
Bal Pharma Technicals
EMA & SMA
Current Price
₹102.65
-0.15 (-0.15%)
- Bullish Moving Average
- ___
- 13
- Bearish Moving Average
- ___
- 3
- 20 Day
- ₹100.16
- 50 Day
- ₹101.89
- 100 Day
- ₹103.28
- 200 Day
- ₹101.43
- 20 Day
- ₹99.89
- 50 Day
- ₹100.21
- 100 Day
- ₹107.27
- 200 Day
- ₹102.21
Bal Pharma Resistance and Support
PIVOT
₹102.7
| Resistance | |
|---|---|
| First Resistance | 104.90 |
| Second Resistance | 107.00 |
| Third Resistance | 109.20 |
| RSI | 55.31 |
| MFI | 67.49 |
| MACD Single Line | -0.49 |
| MACD | -0.16 |
| Support | |
|---|---|
| First Support | 100.60 |
| Second Support | 98.40 |
| Third Supoort | 96.30 |
Bal Pharma Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 41,346 | 2,279,818 | 55.14 |
| Week | 19,962 | 1,275,945 | 63.92 |
| 1 Month | 20,373 | 1,369,069 | 67.2 |
| 6 Month | 65,580 | 3,867,885 | 58.98 |
Bal Pharma Result Highlights
Bal Pharma Synopsis
NSE-Medical-Diversified
Bal Pharma Ltd belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 303.10 Cr. and Equity Capital is Rs. 15.69 Cr. for the Year ended 31/03/2023. Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368.| Market Cap | 162 |
| Sales | 326 |
| Shares in Float | 0.77 |
| No of funds | 1 |
| Yield | 0.99 |
| Book Value | 1.68 |
| U/D Vol ratio | 1.2 |
| LTDebt / Equity | 32 |
| Alpha | -0.08 |
| Beta | 1.48 |
Bal Pharma Shareholding Pattern
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 51.23% | 51.23% | 51.61% | 51.61% |
| Foreign Portfolio Investors | 0.13% | 0.13% | 0.14% | 0.17% |
| Individual Investors | 32.15% | 32.64% | 32.19% | 31.99% |
| Others | 16.49% | 16% | 16.06% | 16.23% |
Bal Pharma Management
| Name | Designation |
|---|---|
| Mr. Shailesh D Siroya | Managing Director |
| Mr. Himesh Virupakshaya | Executive Director |
| Mr. Jatish Sheth | Independent Director |
| Dr. C V Srinivas | Independent Director |
| Ms. Nicloa Neeladri | Independent Director |
| Mr. H S Venkatesh | Independent Director |
| Mr. Kotian Chittananda Damodar | Executive Director |
Bal Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Bal Pharma Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-28 | Audited Results & Final Dividend | |
| 2024-02-12 | Quarterly Results | |
| 2023-11-08 | Quarterly Results & ESOP | |
| 2023-08-11 | Quarterly Results & A.G.M. | |
| 2023-05-29 | Audited Results & Final Dividend |
Bal Pharma FAQs
What is Share Price of Bal Pharma ?
Bal Pharma share price is ₹102 As on 18 May, 2024 | 15:48
What is the Market Cap of Bal Pharma ?
The Market Cap of Bal Pharma is ₹162.2 Cr As on 18 May, 2024 | 15:48
What is the P/E ratio of Bal Pharma ?
The P/E ratio of Bal Pharma is 46.1 As on 18 May, 2024 | 15:48
What is the PB ratio of Bal Pharma ?
The PB ratio of Bal Pharma is 2.5 As on 18 May, 2024 | 15:48